• Adjuvant radiotherapy after radical prostatectomy provided no meaningful benefit in patients with prostate cancer but increased the risk for urinary and bowel morbidity compared with men followed with observation alone, according to the latest results from the phase 3 RADICALS-RT trial. (medscape.com)
  • The new findings showed no difference in the rate of 10-year freedom from distant metastases or overall survival in patients who received adjuvant radiotherapy vs those who underwent observation with salvage radiotherapy if their disease progressed and provided further confirmation of earlier results reported in The Lancet in 2020 . (medscape.com)
  • Invited discussant and session co-chair Shahneen Sandhu, MBBS, said that the findings definitively confirm the value of observation with salvage radiotherapy over adjuvant radiotherapy in this patient population. (medscape.com)
  • In the study, 697 patients were randomly assigned to adjuvant radiotherapy and 699 to observation with salvage radiotherapy. (medscape.com)
  • However, self-reported urinary and fecal incontinence rates at 1 year were significantly higher in the adjuvant radiotherapy group vs the observation group, 60% of whom had not received salvage radiotherapy at that time. (medscape.com)
  • Our study suggests that removing the prostate followed by adjuvant radiotherapy is associated with greater overall survival in men with prostate cancer. (eurekalert.org)
  • Although there are clear criteria (pT3-pT4 disease and/or positive margins) for the use of adjuvant radiotherapy, no specific clinical or tumour-related criteria have yet been defined for SRT. (wjgnet.com)
  • Not all adverse pathology features are equal: Identifying optimal candidates for adjuvant radiotherapy among patients with adverse pathology at radical prostatectomy. (oncologynurseadvisor.com)
  • The Phase II, limited-participation study comparing salvage radiotherapy (SRT) with standard androgen deprivation therapy (ADT) to enhanced ADT with enzalutamide in patients with post-prostatectomy PSA recurrences with aggressive disease features was expected to enroll 170 patients, however the trial official closed to patients with 188 patients accrued. (rtog.org)
  • Although SRT is a widely-accepted treatment option for patients with post-prostatectomy PSA recurrences, including those with aggressive features, up to half of the patients treated with SRT will experience disease progression," stated Edwin Posadas, MD, FACP, of Cedars-Sinai Medical Center and the Principal Investigator of the STEEL study. (rtog.org)
  • Overall, the trial results "support the use of early salvage radiotherapy for PSA failure after radical prostatectomy rather than early adjuvant intervention, " concluded Clarke, a professor and consultant urologist at The Christie Hospital and Salford Royal Hospital, Manchester, United Kingdom. (medscape.com)
  • Available at: radiotherapy for biochemical failure after radical prostatectomy with or. (ehd.org)
  • Observation with early salvage radiotherapy in cases of biochemical failure should be the standard of care, concluded study co-author Noel Clarke, MBBS, who presented the results at the European Society for Medical Oncology (ESMO) Congress 2023 in Madrid on October 20. (medscape.com)
  • The congress brings together esteemed specialists and healthcare professionals from various disciplines, thanks to the collaborative efforts of the European Society for Medical Oncology (ESMO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Association of Urology (EAU). (uroweb.org)
  • Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy," Radiotherapy and Oncology, Vol. 93, No. 1, 2009, pp. 57-63. (scirp.org)
  • According to new findings published in the journal Lancet Oncology, researchers at Princess Margaret Cancer Centre and the Ontario Institute for Cancer Research in Toronto, Ontario, Canada, have designed a genetic test that can determine which men are at the highest risk for developing prostate cancer recurrence following localized surgery or radiotherapy. (cancertherapyadvisor.com)
  • Men with adverse pathology after radical prostatectomy for prostate cancer are a heterogeneous population with different outcomes, according to investigators. (oncologynurseadvisor.com)
  • Adjuvant radiation may reduce the risk for all-cause mortality in a subgroup of men with very high-risk adverse pathologic characteristics at the time of radical prostatectomy for prostate cancer, new findings suggest. (oncologynurseadvisor.com)
  • METHODS: The Regione Emilia-Romagna Italian Longitudinal Health Care Utilization Database was queried to identify a cohort of men who received radical prostatectomy for prostate cancer during 2003 to 2009, including patients who received postprostatectomy radiation therapy. (duke.edu)
  • Prostate cancer is the most common cancer in men and can be treated with radical prostatectomy (RPE) or radiotherapy in the primary setting. (bvsalud.org)
  • Previous research comparing patients treated with radical prostatectomy to radiotherapy-based treatments have generally included patients treated over the span of multiple decades. (ucla.edu)
  • D. Prostate cancer T3 is successfully treated with radical prostatectomy. (imop.gr)
  • They also found there were few side effects with HIFU focal therapy, and that quality-of-life outcomes "compared very favorably" with those from studies of whole-gland treatments, such as radical prostatectomy or radiotherapy. (medpagetoday.com)
  • These functional outcomes compare very favorably to patient-reported outcomes after whole-gland treatments, such as radical prostatectomy and radiotherapy, which, although effective, are associated with substantial and persistent side-effects that impact quality of life," the researchers added. (medpagetoday.com)
  • Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma. (dana-farber.org)
  • 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. (sfu.ca)
  • laparoscopic prostatectomy versus open radical retropubic prostatectomy: Early outcomes from a randomised controlled phase 3 study. (sfu.ca)
  • Comparison of Clinical Outcomes Stratified by Target Delineation for Patients Undergoing Stereotactic Body Radiotherapy for Spinal Metastases. (ohsu.edu)
  • Our findings, in fact, show just the opposite - in this study, the patients with the best outcomes were those who received an aggressive therapy that included so-called 'extremely dose-escalated radiotherapy' along with hormonal therapy. (ucla.edu)
  • Several studies have shown that increasing the dose of radiotherapy beyond standard doses (known as extreme dose-escalation), in combination with hormonal therapy, has improved short-term treatment outcomes, but no previous studies have shown a difference in mortality rates or long-term survival in any group of patients with prostate cancer. (ucla.edu)
  • The STEEL study was designed to address a dire need for improved outcomes for prostate cancer patients with PSA recurrences with aggressive features following prostatectomy. (rtog.org)
  • The evolving culture of cancer care, puting to radiotherapy planning (e.g. nologies undeniably contribute to and cancer medicine more broadly, deep learning to facilitate automated better outcomes for cancer patients has also played a major part in these treatment contouring and planning). (who.int)
  • BACKGROUND: To evaluate efficacy and morbidity prospectively in a contemporary multi-institutional salvage radical prostatectomy (SRP) series. (umassmed.edu)
  • Key eligibility criteria included the indication for radiation therapy after previous radical prostatectomy and no previous postoperative androgen-deprivation therapy. (ascopost.com)
  • Dr. Lu-Yao and colleagues looked at the patients who were treated either with prostatectomy plus adjuvant radiation as one group, and compared them to another group who were treated with radiation therapy plus hormone-blocking therapy. (eurekalert.org)
  • However, the proportion of men undergoing prostatectomy plus radiation therapy decreased significantly over time and there were trade-offs for the survival advantages," said Dr. Lu-Yao. (eurekalert.org)
  • Patients with stage III prostate cancer are curable and have a number of treatment options, including external beam radiation therapy (EBRT) with or without hormone therapy, surgical removal of the cancer with radical prostatectomy, or active surveillance without immediate treatment. (texasoncology.com)
  • Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer," The Journal of the American Medical Association, Vol. 280, 1998, pp. 969-974. (scirp.org)
  • PURPOSE: Although the likelihood of radiation-related adverse events influences treatment decisions regarding radiation therapy after prostatectomy for eligible patients, the data available to inform decisions are limited. (duke.edu)
  • RESULTS: A total of 9876 men were included in the analyses: 2176 (22%) who received radiation therapy and 7700 (78%) treated with prostatectomy alone. (duke.edu)
  • CONCLUSION: Radiation therapy after prostatectomy is associated with an increase in gastrointestinal and genitourinary adverse events. (duke.edu)
  • The addition of 24 months of androgen-deprivation therapy to postoperative radiotherapy after radical prostatectomy provided a metastasis-free survival benefit and improved the time to salvage therapy in patients with prostate cancer, according to the preliminary results from the RADICALS-HD trial (ISRCTN40814031). (ascopost.com)
  • When men are getting radiotherapy for prostate cancer as their initial treatment, we know the addition of hormone therapy improves efficacy and survival. (ascopost.com)
  • Based on the first results of the RADICALS-HD trial, 24 months of androgen-deprivation therapy with radiotherapy after radical prostatectomy improved metastasis-free survival, compared with 6 months of androgen-deprivation therapy, with a 10-year rate of metastasis-free survival of 78% vs 72%, respectively. (ascopost.com)
  • However, overall survival was not improved with a long vs short course of androgen-deprivation therapy with radiotherapy after surgery. (ascopost.com)
  • In this high-risk group RT + 24 months of ADT after prostatectomy improved overall survival. (prostatecancerfree.org)
  • With the PSA test it is now possible to detect cancer of the prostate earlier and with the introduction of the selective radical prostatectomy excellent cure rates of 15 and 20 year survival rates are achieved, which for practical purposes can be considered a cure. (nethealthbook.com)
  • However, for stage C and D where the cancer has broken through the tough prostate capsule surgery gives no survival advantage versus the radiotherapy approach. (nethealthbook.com)
  • Therefore only external radiotherapy is available as an option to marginally improve survival. (nethealthbook.com)
  • D espite the stage migration and concomitant improvements in prostate cancer-specific survival (PCSS) associated with widespread prostate-specific antigen (PSA) screening, approximately 1 in 3 men with clinically localized disease will develop a detectable PSA after radical prostatectomy (RP) in contemporary series. (jnccn.org)
  • 2 The argument for postoperative radiotherapy (RT) is predicated on the assumption that some patients may have residual local disease of a potentially lethal phenotype after surgery and that the delivery of secondary local therapy may interrupt the natural history of disease and prevent progression to systemic disease. (jnccn.org)
  • Postoperative radiotherapy after prostatectomy: whom to treat. (canjurol.com)
  • Men with very high-risk prostate cancer, who are treated at hospitals with a high proportion of administered radical local treatment (radiotherapy or prostatectomy), only have half of the mortality risk of men who are treated at hospitals with the lowest proportion. (news-medical.net)
  • Monotherapy with curative intent, either by radical prostatectomy or radiotherapy, results in around half. (karger.com)
  • For example, a patient was just treated with curative intent with either radical prostatectomy or radical radiotherapy. (uroweb.org)
  • Failure after salvage radiotherapy is most likely due to disease outside the prostate bed, which can include the pelvic lymph nodes, paraaortic lymph nodes, and distant metastases. (snmjournals.org)
  • Before a prostatectomy is performed, patients may want to have pelvic lymph nodes removed to see if they contain cancer. (texasoncology.com)
  • Outcome measures were genitourinary, gastrointestinal, and sexual adverse events after prostatectomy. (duke.edu)
  • It compared two treatments initiated after a PSA rise to between 0.2 - 4.0 ng/mL after a prostatectomy and lymphadenectomy. (prostatecancerfree.org)
  • One of the treatments applied in cancer is radiotherapy (RT), a therapeutic modality that uses ionizing radiation to induce damage in unwanted cells. (frontiersin.org)
  • UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate of men with aggressive prostate cancer. (ucla.edu)
  • Methods: Review of data from several historical and contemporary series of patients undergoing radical prostatectomy. (karger.com)
  • Aims and background: we evaluate CT-3Tesla MRI fusion in conformal radiotherapy for localized prostate cancer.Methods: 18 consecutive patients underwent a 3T MRI scan under radiotherapy planning conditions, after the CT scan. (scirp.org)
  • Prostatectomy is an unpopular treatment," said Lu-Yao. (eurekalert.org)
  • In an elderly man who may soon die of a stroke or a heart attack this might still be the treatment of choice as a selective radical prostatectomy is a certain surgical risk. (nethealthbook.com)
  • Active treatment is mostly recommended for patients with localised disease and a long life expectancy with radical prostatectomy (RP) shown to be superior to WW in a prospective randomised trial. (nih.gov)
  • Performance of a Genomic Classifier (GC) Within a Phase 3 Randomized Trial of Dose Escalated Salvage Radiotherapy (SRT) After Radical Prostatectomy (RP). (cdc.gov)
  • Radiotherapy Dose in Patients Receiving Immunotherapy. (dana-farber.org)
  • The dose-volume histogram (DVH) analysis shows a significant reduction of the dose received by the rectum and the penile bulb in MRI-plans compared to CT-plans.Conclusions: 3 Tesla MRI scan under radiotherapy planning conditions along with bowel preparation significantly improves the definition of the target volume sparing normal tissue irradiation. (scirp.org)
  • Patients in the observation arm received salvage radiotherapy if they experienced two consecutive PSA increases ≥ 0.1 ng/mL or three consecutive rises. (medscape.com)
  • 18. For patients who presented biochemical relapse after radical prostatectomy, which of the following factors are related more to local relapse than to remote metastasis? (imop.gr)
  • 2) Spratt concluded: "Pre-salvage radiotherapy PSA is both a prognostic and true predictive biomarker for benefit of hormone therapy combined with salvage radiation. (prostatecancerfree.org)